Autoantigen administration in an animal model of diabetes prevents development of the disease even after insulitis is established (pages 1348–1353).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tian, J. et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature Med. 2, 1348–1353 (1996).
Harrison, L.C. Antigen-specific therapy for autoimmune disease: Prospects for the prevention of insulin-dependent diabetes. Molec. Med. 1, 722–727 (1995).
Verge, C.F. et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512/IA-2 autoantibodies. Diabetes 45, 926–933 (1996).
Tyden, G., Reinholt, F.P., Sundkvist, G. & Bolinder, J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N. Eng. J. Med. 335, 860–863 (1996).
Solimena, M. & De Camilli, P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 14, 452–457 (1991).
Kaufman, D.L. et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69–72 (1993).
Tisch, R. et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72–75 (1993).
Elliott, J.F. et al. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune disease in NOD mice. Diabetes 43, 1494–1499 (1994).
Petersen, J.S. et al. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 43, 1478–1484 (1994).
Pleau, J.M., Fernandez-Saravia, F., Esling, A., Homo-Delarche, F. & Dardenne, M. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clin. Immunol. Immunopath. 76, 90–95 (1995).
Forsthuber, T., Yip, H.C. & Lehmann, P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science 271, 1728–1730 (1996).
Tian, J. et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. exp. Med. 183, 1561–1567 (1996).
Elias, D. & Cohen, I.R. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Lancet 343, 704–706 (1994).
Keller, R.J., Eisenbarth, G.S. & Jackson, R.A. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341, 927–928 (1993).
Haskins, K. & Wegmann, D. Diabetogenic T-cell clones. Diabetes 45, 1299–1305 (1996).
Katz, J.D., Benoist, C. & Mathis, D. T helper cell subsets in insulin-dependent diabetes. Science 268, 1185–1188 (1995).
Serreze, D.V., Leiter, E.H., Christianson, G.J., Greiner, D. & Roopenian, D.C. Major histocompatibility complex class I-deficient NOD B2-null mice are diabetes and insulitis resistant. Diabetes 43, 505–509 (1994).
Wicker, L.S. et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 505–509 (1994).
Wong, F.S., Visintin, I., Wen, L., Flavell, R.A. & Janeway, C.A. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183, 67–76 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solimena, M., Camilli, P. From Th1 to Th2: Diabetes immunotherapy shifts gears. Nat Med 2, 1311–1312 (1996). https://doi.org/10.1038/nm1296-1311
Issue Date:
DOI: https://doi.org/10.1038/nm1296-1311
